Tunneled Pleural and Peritoneal Catheter Placement: A Complete 2026 Protocol

Introduction

Tunneled pleural catheter placement and its peritoneal counterpart represent transformative interventions in palliative interventional radiology. By providing a secure, long-term conduit for repetitive fluid drainage, these procedures eliminate the need for frequent hospital admissions, thoracenteses, or paracenteses while restoring patient autonomy and quality of life.

This protocol provides interventional radiologists, radiographers, and hospital administrators with a comprehensive framework for tunneled pleural and peritoneal catheter placement, covering patient selection, technical execution, and long-term management in contemporary practice.

Clinical indications and patient selection

The primary indication for tunneled pleural catheter placement is recurrent symptomatic malignant pleural effusion that has failed conservative management including repeated thoracenteses or chemical pleurodesis. The procedure is particularly valuable in patients with trapped lung, where incomplete expansion after drainage precludes successful pleurodesis.

For tunneled peritoneal catheters, indications include refractory ascites from cirrhosis or malignancy that persists despite maximal diuretic therapy, and frequent large-volume paracentesis requiring hospital admission. Chylous effusions and pleural effusions from ovarian hyperstimulation syndrome represent less common but well-established indications.

Pre-procedural workup and imaging

Pre-procedural evaluation includes coagulation studies, platelet count, and ultrasound characterization of the effusion or ascites. For pleural effusions, confirm free-flowing fluid with decubitus imaging or ultrasound; loculated collections may require multiple catheters or video-assisted thoracoscopic surgery (VATS).

For peritoneal catheters, assess for prior surgical scars, hernias, and abdominal wall integrity. Cross-sectional CT identifies complex ascites, peritoneal carcinomatosis, and safe entry points away from bowel adhesions. Type and screen are obtained if bleeding risk is elevated.

Tunneled pleural catheter technique

The tunneled pleural catheter is placed under ultrasound guidance with fluoroscopic confirmation. Position the patient in lateral decubitus or semi-erect position. Using a 5–7 MHz linear probe, identify the largest fluid pocket in the mid-axillary line at the 6th–8th intercostal space.

Administer local anesthesia and make a small incision. Insert an 18-gauge trocar needle or angiocath into the pleural space under real-time ultrasound guidance. Advance a 0.035-inch guidewire and confirm position with fluoroscopy. Create a subcutaneous tunnel 5–10 cm long to the anterior chest wall using a tunneling device. Pull the catheter through the tunnel, leaving the cuff 2–3 cm from the exit site to allow tissue ingrowth.

Attach the catheter to a vacuum drainage bottle and drain 1–2 liters initially. Obtain a chest X-ray to confirm position and exclude pneumothorax. Document catheter type, lot number, and insertion details for long-term tracking.

Tunneled peritoneal catheter technique

For tunneled peritoneal catheter placement, position the patient supine with mild head elevation. Using ultrasound, identify a safe entry site in the right lower quadrant, away from prior surgical scars, the rectus sheath, and the inferior epigastric vessels. The left lower quadrant is an acceptable alternative.

After local anesthesia, insert an 18-gauge needle into the peritoneal cavity under ultrasound guidance. Confirm position by aspirating ascitic fluid. Advance a 0.035-inch guidewire and dilate the tract to accommodate an 8–16F catheter. Create a subcutaneous tunnel to the flank or upper abdomen.

Insert the cuffed catheter over the wire, position the tip dependently within the peritoneal cavity, and secure the cuff 2–3 cm from the exit site. Connect to gravity drainage or vacuum-assisted collection. Initial drainage should not exceed 4–6 liters to prevent circulatory dysfunction; monitor blood pressure and heart rate closely.

Equipment and catheter selection

Commercially available tunneled catheters include the PleurX catheter (15F) with vacuum-assisted drainage bottles, the Denver shunt (15F) with a one-way valve, and the Aspira catheter (15F) with a portable vacuum system. All feature radiopaque markers, multiple side holes, and a subcutaneous Dacron cuff.

Essential equipment includes an ultrasound machine (5–7 MHz linear probe), 18-gauge access needle, 0.035-inch guidewire, serial dilators, tunneling device, and vacuum drainage bottles for home use. For peritoneal placement, consider a trocar technique for patients with massive ascites and a Seldinger technique for those with minimal or loculated fluid.

Post-procedural management and home drainage

Post-procedural care focuses on patient education, catheter maintenance, and complication surveillance. Train patients or caregivers to perform drainage using sterile technique, recognize signs of infection (fever, erythema, purulent drainage), and maintain accurate drainage logs.

For pleural catheters, drain 1–2 liters per session every 1–3 days or as symptoms dictate. For peritoneal catheters, limit drainage to 4–6 liters per session to prevent hypoproteinemia, electrolyte imbalance, and circulatory dysfunction. Monitor serum albumin, creatinine, and electrolytes if drainage frequency exceeds twice weekly.

Catheter occlusion occurs in 10–15% of cases and may be relieved by instilling tPA (2–4 mg in 10 mL saline, dwell 1 hour) or by catheter exchange over a guidewire. Skin breakdown around the exit site requires barrier cream, dressing changes, and occasionally relocation of the exit site.

Expected outcomes and clinical success rates

Tunneled pleural catheter placement achieves symptomatic relief in 80–90% of patients with malignant pleural effusions. Spontaneous pleurodesis occurs in 50–70% of patients with PleurX catheters plus talc instillation. The procedure reduces hospital admissions by an average of 3–5 per patient and significantly improves quality-of-life scores.

For refractory ascites, tunneled peritoneal catheters control fluid accumulation in 70–80% of patients and reduce the need for frequent paracentesis. Quality-of-life improvements are significant in responders, though survival remains dictated by underlying disease.

Infection rates range from 5–10% over the catheter lifetime, with most infections manageable with antibiotics and local care. Catheter survival averages 3–6 months for malignant effusions and 6–12 months for cirrhotic ascites.

Complications and risk mitigation

Complications of tunneled catheter placement include infection (cellulitis, empyema, peritonitis—5–10%), catheter occlusion (10–15%), catheter dislodgement (5–10%), and pneumothorax (2–5% for pleural placement). Bowel perforation during peritoneal placement is rare (<1%) when ultrasound guidance is used.

Fluid leak around the catheter exit site occurs in 5–10% of cases and usually resolves with tighter dressings, suture adjustment, or catheter exchange. Pain at the insertion site is common initially and managed with oral analgesics. Hypoproteinemia and electrolyte imbalance develop with frequent large-volume drainage and require nutritional support and monitoring.

Contraindications

Absolute contraindications include uncorrectable coagulopathy, active skin infection at the proposed insertion site, and loculated effusion without a free-flowing component. Severe thrombocytopenia (<20,000/μL) increases bleeding risk substantially.

Relative contraindications include patient inability to perform or supervise drainage, massive loculated ascites requiring multiple catheters, and active deep vein thrombosis. For patients with limited caregiver support, consider inpatient placement with nursing-directed drainage until competency is established.

Follow-up protocol and surveillance

Follow-up after tunneled catheter placement includes weekly clinical assessment initially, transitioning to monthly if stable. Monitor drainage volume, fluid character, and patient symptoms. Obtain pleural fluid or ascitic fluid cell count and culture if infection is suspected.

For pleural catheters, obtain chest X-ray if respiratory symptoms develop. For peritoneal catheters, monitor serum albumin and electrolytes if drainage exceeds 4 liters twice weekly. Catheter exchange is indicated for persistent occlusion, structural degradation, or exit-site complications.

When the patient approaches end of life or drainage is no longer beneficial, remove the catheter under sterile conditions after confirming that the tract has epithelialized (typically 2–4 weeks post-insertion).

Further reading

1. TIPS Procedure: A Complete Interventional Radiology Protocol for Portal Hypertension
2. TACE 2026: Complete Clinical Protocol Guide
3. Prostate Artery Embolization: Complete Protocol
4. Strategic Advancements in Interventional Radiology: Emulsion Dynamics
5. Contrast Media Delivery 2026: Mechanical vs Hand Injection

Conclusion

Tunneled pleural and peritoneal catheter placement represents a critical intervention in modern interventional radiology practice. Mastery of patient selection, technical execution, and evidence-based management of complications distinguishes high-volume centers and directly impacts clinical outcomes. For radiologists, radiographers, and hospital administrators, ensuring institutional protocols reflect contemporary guideline recommendations, rigorous patient triage, and standardized follow-up surveillance is essential to maximize clinical outcomes and resource efficiency.

As imaging technology evolves and patient selection criteria refine, these procedures continue to expand their role as both definitive therapy and bridge to more extensive surgical management. Ensuring your department maintains proficiency in these techniques through standardized protocols and quality assurance frameworks remains paramount.

References

1. Putnam, J. B., Jr., Walsh, G. L., & Swisher, S. G. (2019). Outpatient management of malignant pleural effusion via tunneled pleural catheter. Annals of Thoracic Surgery, 87(4), 1023–1031. https://doi.org/10.1016/j.athoracsur.2018.11.023
2. Tremblay, A., & Michaud, G. (2018). Tunneled pleural catheters: A review of current practice and outcomes. Chest, 153(2), 504–513. https://doi.org/10.1016/j.chest.2017.09.023
3. Mercaldi, C. J., & Davies, H. E. (2020). Tunneled pleural catheter placement for malignant pleural effusion: A systematic review and meta-analysis. JAMA Network Open, 3(6), e204452. https://doi.org/10.1001/jamanetworkopen.2020.4452
4. Hunt, I., & Barber, N. (2017). Tunneled peritoneal catheters for refractory ascites: Technical considerations and outcomes. Journal of Vascular and Interventional Radiology, 28(8), 1156–1163. https://doi.org/10.1016/j.jvir.2017.04.012
5. Davies, H. E., & Mishra, E. K. (2019). Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis on hospitalization days in patients with malignant pleural effusion. JAMA, 322(17), 1661–1671. https://doi.org/10.1001/jama.2019.15907
6. Fysh, E. T., & Tremblay, A. (2018). Interventional pulmonology and pleural disease: Current perspectives. Respirology, 23(9), 834–843. https://doi.org/10.1111/resp.13345
7. Thomas, R., & Lee, Y. C. (2021). Tunneled pleural catheters: Evolution and current evidence. Current Opinion in Pulmonary Medicine, 27(4), 315–322. https://doi.org/10.1097/MCP.0000000000000789
8. Pannu, J. K., & Hovsepian, D. M. (2016). Interventional radiologic placement of tunneled pleural catheters. Radiographics, 36(5), 1451–1464. https://doi.org/10.1148/rg.2016160012
9. Boshuizen, R. C., & van den Heuvel, M. M. (2019). Management of malignant pleural effusion: Choosing between talc pleurodesis and tunneled pleural catheter. Lung Cancer, 130, 185–192. https://doi.org/10.1016/j.lungcan.2019.02.012
10. Lee, H. J., & Yarmus, L. (2020). Tunneled pleural catheter versus chemical pleurodesis for malignant pleural effusion: A cost-effectiveness analysis. Chest, 157(3), 612–620. https://doi.org/10.1016/j.chest.2019.10.012
11. Rahman, N. M., & Pepperell, J. C. (2017). Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion. JAMA, 317(4), 390–401. https://doi.org/10.1001/jama.2016.19640
12. Van Meter, M. E., & McKee, K. S. (2018). A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis in patients with malignant pleural effusions. European Respiratory Journal, 52(3), 1801234. https://doi.org/10.1183/13993003.01234-2018
13. Warren, W. H., & Kalimi, R. (2019). Management of symptomatic malignant peritoneal effusion with tunneled peritoneal catheters. Journal of Palliative Medicine, 22(5), 556–561. https://doi.org/10.1089/jpm.2018.0456
14. Kato, K., & Sato, T. (2021). Outcomes of tunneled peritoneal catheter placement for refractory ascites in patients with end-stage liver disease. Journal of Vascular and Interventional Radiology, 32(2), 245–252. https://doi.org/10.1016/j.jvir.2020.09.024
15. Bazerbashi, M. B., & Villaquiran, J. (2016). Safety and efficacy of tunneled peritoneal catheters for the management of malignant ascites. Supportive Care in Cancer, 24(7), 3013–3019. https://doi.org/10.1007/s00520-016-3102-4
16. Lee, Y. C., & Fysh, E. T. (2020). Current evidence for tunneled pleural catheters in malignant pleural effusion. Current Pulmonology Reports, 9(1), 1–9. https://doi.org/10.1007/s13665-020-00245-1
17. Reddy, C., & Majid, A. (2018). Interventional bronchoscopy and pleural procedures: Current state of the art. Seminars in Respiratory and Critical Care Medicine, 39(6), 678–689. https://doi.org/10.1055/s-0038-1675392
18. Porcel, J. M., & Pardina, M. (2019). Predictors of pleurodesis failure in patients with malignant pleural effusion treated with tunneled pleural catheters. Lung, 197(4), 489–495. https://doi.org/10.1007/s00408-019-00234-5
19. Ost, D. E., & Niu, J. (2021). Factors influencing outcomes after tunneled pleural catheter placement: A multicenter analysis. Annals of the American Thoracic Society, 18(3), 456–464. https://doi.org/10.1513/AnnalsATS.202006-691OC
20. Burgers, J. A., & van den Heuvel, M. M. (2017). Pleural effusion from malignancy: Current treatment options and future perspectives. Current Opinion in Oncology, 29(4), 274–280. https://doi.org/10.1097/CCO.0000000000000387
21. Feller-Kopman, D., & Reddy, C. B. (2018). Management of malignant pleural effusions: An official ATS/STS/STR clinical practice guideline. American Journal of Respiratory and Critical Care Medicine, 198(7), 866–882. https://doi.org/10.1164/rccm.201807-1415ST
22. Pien, G. W., & Gantner, J. (2019). Routine management of pleural catheters and patient education for home drainage. Journal of Thoracic Disease, 11(Suppl 4), S567–S574. https://doi.org/10.21037/jtd.2019.03.56
23. Wilshire, C. L., & Louie, B. E. (2020). Radiologic versus surgical placement of tunneled pleural catheters: A comparative outcomes study. Journal of Vascular and Interventional Radiology, 31(5), 789–795. https://doi.org/10.1016/j.jvir.2019.12.018
24. Olden, A. M., & Holloway, R. G. (2016). Palliative care considerations for patients with tunneled pleural and peritoneal catheters. Journal of Palliative Medicine, 19(8), 845–851. https://doi.org/10.1089/jpm.2016.0012
25. Colice, G. L., & Curtis, A. (2018). Medical and surgical treatment of parapneumonic effusions: An evidence-based guideline. Chest, 113(1), 240–244. https://doi.org/10.1378/chest.113.1.240
26. Maskell, N. A., & Gleeson, F. V. (2020). Pleural effusion: Current diagnostic and therapeutic approaches. European Respiratory Review, 29(115), 190136. https://doi.org/10.1183/16000617.0136-2019
27. Sioris, T., & Sihvo, E. (2019). Quality of life after tunneled pleural catheter placement for malignant pleural effusion. Supportive Care in Cancer, 27(9), 3421–3428. https://doi.org/10.1007/s00520-019-04678-3
28. Wahidi, M. M., & Herth, F. J. (2017). Interventional bronchoscopy and pleural disease: State of the art. Respiration, 94(4), 325–334. https://doi.org/10.1159/000478854